Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer
Clinical trial NCT00286247 · COMPLETED
Trial details
- NCT number
- NCT00286247
- Sponsor
- Introgen Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.